Bovine herpesvirus 1 VP22 enhances the efficacy of a DNA vaccine in cattle

Journal of Virology

Volumn 79, Issue 3, 2005, Pages 1948-1953

  Zheng, Chunfu ^a   Babiuk, Lorne A ^a   Van Drunen Littel Van Den Hurk, Sylvia ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; GLYCOPROTEIN D; PROTEIN VP22; BOVINE HERPESVIRUS TYPE 1 GLYCOPROTEINS; BOVINE HERPESVIRUS TYPE-1 GLYCOPROTEINS; HERPES VACCINE; HYBRID PROTEIN; IMMUNOLOGICAL ADJUVANT; TEGUMENT PROTEIN VP22, BOVINE HERPESVIRUS 1; VIRUS ANTIBODY; VIRUS PROTEIN;

ANALYSIS OF VARIANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN PRESENTATION; ARTICLE; BOVINE HERPES VIRUS; CATTLE; CELL STRAIN COS7; CELLULAR IMMUNITY; CONTROLLED STUDY; DNA TRANSFECTION; DRUG EFFICACY; DRUG MECHANISM; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; INFECTION PREVENTION; INFECTION RESISTANCE; INTRACELLULAR TRANSPORT; MOLECULAR CLONING; NONHUMAN; OPEN READING FRAME; PLASMID; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TRANSPORT; PROVOCATION TEST; TECHNIQUE; VIRUS INFECTION; VIRUS LOAD; VIRUS NEUTRALIZATION; VIRUS REACTIVATION; VIRUS SHEDDING; VIRUS STRAIN; ANIMAL; ANIMAL DISEASE; BLOOD; CATTLE DISEASE; CELL STRAIN COS1; GENETICS; HERPES VIRUS INFECTION; IMMUNOLOGY; INFECTIOUS BOVINE RHINOTRACHEITIS VIRUS; METABOLISM; VIROLOGY;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; CATTLE; CATTLE DISEASES; COS CELLS; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, BOVINE; HERPESVIRUS VACCINES; IMMUNIZATION; RECOMBINANT FUSION PROTEINS; VACCINES, DNA; VIRAL PROTEINS; VIRAL STRUCTURAL PROTEINS;

EID: 13744255351     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.3.1948-1953.2005     Document Type: Article

References (34)

1. Aints, A., M. S. Dilber, and C. I. Smith. 1999. Intercellular spread of GFP-VP22. J. Gene Med. 1:275-279.
2. Bahiuk, L. A., R. Pontarollo, S. Bahiuk, B. Loehr, and S. van Drunen Littel-van den Hurk. 2003. Induction of immune responses by DNA vaccines in large animals. Vaccine 21:649-658.
3. Bosch, J. C., M. C. De Jong, P. Franken, K. Frankena, J. J. Hage, M. J. Kaashoek, M. A. Maris-Veldhuis, J. P. Noordhuizen, W. H. Van der Poel, J. Verhoeff, K. Weerdmeester, G. M. Zimmer, and J. T. Van Oirschot. 1998. An inactivated gE-negative marker vaccine and an experimental gD-subunit vaccine reduce the incidence of bovine herpesvirus 1 infections in the field. Vaccine 16:265-271.
4. Brewis, N., A. Phelan, J. Webb, J. Drew, G. Elliott, and P. O'Hare. 2000. Evaluation of VP22 spread in tissue culture. J. Virol. 74:1051-1056.
5. Cheng, W. F., C. F. Hung, K. F. Hsu, C. Y. Chai, L. He, J. M. Polo, L. A. Slater, M. Ling, and T. C. Wu. 2002. Cancer immunotherapy using Sindbis virus replicon particles encoding a VP22-antigen fusion. Hum. Gene Ther. 13:553-568.
6. Constant, S. L., and K. Bottomly. 1997. Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. Annu. Rev. Immunol. 15:297-322.
7. Deshpande, M. S., T. C. Ambagala, N. R. Hegde, M. J. Hariharan, M. Navaratnam, and S. Srikumaran. 2002. Induction of cytotoxic T-lymphocytes specific for bovine herpesvirus-1 by DNA immunization. Vaccine 20: 3744-3751.
8. Dilber, M. S., A. Phelan, A. Aints, A. J. Mohamed, G. Elliott, C. I. Smith, and P. O'Hare. 1999. Intercellular delivery of thymidine kinase prodrug activating enzyme by the herpes simplex virus protein, VP22. Gene Ther. 6:12-21.
9. Elliott, G., and P. O'Hare. 1997. Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell 88:223-233.
10. Fang, B., B. Xu, P. Koch, and J. A. Roth. 1998. Intercellular trafficking of VP22-GFP fusion proteins is not observed in cultured mammalian cells. Gene Ther. 5:1420-1424.
11. Feltquate, D. M., S. Heaney, R. G. Webster, and H. L. Robinson. 1997. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J. Immunol. 158:2278-2284.
12. Hariharan, M. J., C. Nataraj, and S. Srikumaran. 1993. Down regulation of murine MHC class I expression by bovine herpesvirus 1. Virol Immunol. 6:273-284.
13. Harms, J. S., X. Ren, S. C. Oliveira, and G. A. Splitter. 2000. Distinctions between bovine herpesvirus 1 and herpes simplex virus type 1 VP22 tegument protein subcellular associations. J. Virol. 74:3301-3312.
14. Hung, C. F., W. F. Cheng, C. Y. Chai, K. F. Hsu, L. He, M. Ling, and T. C. Wu. 2001. Improving vaccine potency through intercellular spreading and enhanced MHC class I presentation of antigen. J. Immunol. 166:5733-5740.
15. Hung, C. F., L. He, J. Juang, T. J. Lin, M. Ling, and T. C. Wu. 2002. Improving DNA vaccine potency by linking Marek's disease virus type 1 VP22 to an antigen. J. Virol. 76:2676-2682.
16. Ioannou, X. P., P. Griebel, R. Hecker, L. A. Babiuk, and S. van Drunen Littel-van den Hurk. 2002. The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus Emulsigen are increased by formulation with CpG oligodeoxynucleotides. J. Virol. 76:9002-9010.
17. Kim, T. W., C. F. Hung, J. W. Kim, J. Juang, P. J. Chen, L. He, D. A. Boyd, and T. C. Wu. 2004. Vaccination with a DNA vaccine encoding herpes simplex virus type 1 VP22 linked to antigen generates long-term antigen-specific CD8-positive memory T cells and protective immunity. Hum. Gene Ther. 15:167-177.
18. Liang, X., B. Chow, Y. Li, C. Raggo, D. Yoo, S. Attah-Poku, and L. A. Babiuk. 1995. Characterization of bovine herpesvirus 1 UL49 homolog gene and product: bovine herpesvirus 1 UL49 homolog is dispensable for virus growth. J. Virol. 69:3863-3867.
19. Loehr, B. I., R. Pontarollo, R. Rankin, L. Latimer, P. Willson, L. A. Babiuk, and S. van Drunen Littel-van den Hurk. 2001. Priming by DNA immunization augments T-cell responses induced by modified live bovine herpesvirus vaccine. J. Gen. Virol. 82:3035-3043.
20. Lundberg, M., and M. Johansson. 2001. Is VP22 nuclear homing an artifact? Nat. Biotechnol. 19:713-714.
21. Mars, M. H., M. C. de Jong, P. Franken, and J. T. van Oirschot. 2001. Efficacy of a live glycoprotein E-negative bovine herpesvirus 1 vaccine in cattle in the field. Vaccine 19:1924-1930.
22. Michel, N., W. Osen, L. Gissmann, T. N. Schumacher, H. Zentgraf, and M. Muller. 2002. Enhanced immunogenicity of HPV 16 E7 fusion proteins in DNA vaccination. Virology 294:47-59.
23. Nataraj, C., S. Eidmann, M. J. Hariharan, J. H. Sur, G. A. Perry, and S. Srikumaran. 1997. Bovine herpesvirus 1 downregulates the expression of bovine MHC class I molecules. Virol Immunol. 10:21-34.
24. Oliveira, S. C., J. S. Harms, R. R. Afonso, and G. A. Splitter. 2001. A genetic immunization adjuvant system based on BVP22-antigen fusion. Hum. Gene Ther. 12:1353-1359.
25. Phelan, A., G. Elliott, and P. O'Hare. 1998. Intercellular delivery of functional p53 by the herpesvirus protein VP22. Nat. Biotechnol. 16:440-443.
26. Pontarollo, R. A., L. A. Babiuk, R. Hecker, and S. van Drunen Littel-van den Hurk. 2002. Augmentation of cellular immune responses to bovine herpes-virus-1 glycoprotein D by vaccination with CpG-enhanced plasmid vectors. J. Gen. Virol. 83:2973-2981.
27. Raggo, C., M. Habermehl, L. A. Babiuk, and P. Griebel. 2000. The in vivo effects of recombinant bovine herpesvirus-1 expressing bovine interferon-gamma. J. Gen. Virol. 81:2665-2673.
28. Van Donkersgoed, J., D. McCartney, and S. van Drunen Littel-van den Hurk. 1996. Efficacy of an experimental BHV-1 subunit gIV vaccine in beef calves challenged with BHV-1 in aerosol. Can. J. Vet. Res. 60:55-58.
29. van Drunen Littel-van den Hurk, S., R. P. Braun, B. C. Karvonen, T. King, D. Yoo, and L. A. Babiuk. 1999. Immune responses and protection induced by DNA vaccines encoding bovine parainfluenza virus type 3 glycoproteins. Virology 260:35-46.
30. van Drunen Littel-van den Hurk, S., G. A. Gifford, and L. A. Babiuk. 1990. Epitope specificity of the protective immune response induced by individual bovine herpesvirus-1 glycoproteins. Vaccine 8:358-368.
31. van Drunen Littel-van den Hurk, S., J. Van Donkersgoed, J. Kowalski, J. V. van den Hurk, R. Harland, L. A. Babiuk, and T. J. Zamb. 1994. A subunit gIV vaccine, produced by transfected mammalian cells in culture, induces mucosal immunity against bovine herpesvirus-1 in cattle. Vaccine 12:1295-1302.
32. Whetstone, C. A., J. G. Wheeler, and D. E. Reed. 1986. Investigation of possible vaccine-induced epizootics of infectious bovine rhinotracheitis, using restriction endonuclease analysis of viral DNA. Am. J. Vet. Res. 47: 1789-1795.
33. Wills, K. N., I. A. Atencio, J. B. Avanzini, S. Neuteboom, A. Phelan, J. Philopena, S. Sutjipto, M. T. Vaillancourt, S. F. Wen, R. O. Ralston, and D. E. Johnson. 2001. Intratumoral spread and increased efficacy of a p53-VP22 fusion protein expressed by a recombinant adenovirus. J. Virol. 75: 8733-8741.
34. Yates, W. D. G. 1982. A review of infectious bovine rhinotracheitis, shipping fever pneumonia and viral-bacterial synergism in respiratory disease of cattle. Can. J. Comp. Med. 46:225-263.